Clinical Trial: Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
Study Status: Completed
Recruit Status: RECRUITING
Condition: Myeloid Neoplasm
Study Type: INTERVENTIONAL
Official Title: A Prospective, Multicenter, Single-Arm Pilot Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
Brief Summary:
The purpose of this study is to learn the effects of treatment with an investigational drug, CPX-351 in patients with secondary myeloid neoplasms (SMNs).
Read more